EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative performance of the Platelia Aspergillus Antigen and Aspergillus Galactomannan antigen Virclia Monotest immunoassays in serum and lower respiratory tract specimens: a “real-life” experience

Eliseo Albert iD, María Jesús Alcaraz, Estela Giménez, María Ángeles Clari, Ignacio Torres, Javier Colomina, Beatriz Olea, Mar Tormo, José Luis Piñana, Rosa Oltra, Jaime Signes-Costa, Nieves Carbonell iD und 2 weitere

Microbiology Spectrum · 06.08.2024 · 12 (8)

DOI: 10.1128/spectrum.03910-23 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 06.08.2024. Verfasst von Eliseo Albert und 13 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Hauptthemen laut MEDLINE: Galactose, Mannans, Antigens, Fungal, Aspergillus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEC | Instituto de Salud Carlos III (ISCIII).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Platelia Aspergillus Antigen immunoassay is the “gold standard” for Aspergillus galactomannan (GLM) measurement in sera and bronchoalveolar lavage (BAL) for the diagnosis of invasive pulmonary aspergillosis (IPA). We evaluated the performance of the Aspergillus GLM antigen Virclia Monotest compared to the Platelia assay. A total of 535 specimens [320 sera, 86 bronchial aspirates (BAs), 70 BAL, and 59 tracheal aspirates (TAs)] from 177 adult patients (72 hematological, 32 Intensive Care Unit, and 73 hospitalized in other wards) were processed for GLM testing upon clinical request. One patient had proven IPA, and 11 had probable disease. After excluding indeterminate Virclia results ( n = 38), 396 specimens yielded concordant results (56 positive and 340 negative) and 101 discordant results (Virclia positive/Platelia negative, n = 95). The overall agreement between immunoassays was higher for sera ( κ 0.56) than for BAL ( κ ≤ 0.24) or BAS and TA ( κ ≤ 0.22). When considering all specimen types in combination, the overall sensitivity and specificity of the Virclia assay for the diagnosis of proven/probable IPA were 100% and 65%, respectively, and for the Platelia immunoassay, sensitivity and specificity were 91.7% and 89.4%, respectively. The correlation between index values by both immunoassays was strong for serum/BAL ( ρ = 0.73; P < 0.001) and moderate for BAS/TA (Rho = 0.52; P = 0.001). The conversion of Virclia index values into the Platelia index could be derived by the formula y = (11.97 * X )/3.62 + X ). Data from GLM-positive serum/BAL clinical specimens fitted the regression model optimally ( R 2 = 0.94), whereas that of BAS and TA data did not ( R 2 = 0.11). Further studies are needed to determine whether the Virclia assay may be an alternative to the Platelia assay for GLM measurement in sera and lower respiratory tract specimens. IMPORTANCE Galactomannan detection in serum or bronchoalveolar fluid specimens is pivotal for the diagnosis of invasive pulmonary aspergillosis (IPA). The Platelia Aspergillus Antigen immunoassay has become the “gold standard” for Aspergillus GLM measurement. Here, we provide data suggesting that the Virclia Monotest assay, which displays several operational advantages compared with the Platelia assay, may become an alternative to the Platelia assay, although further studies are needed to validate this assumption. We also provide a formula allowing the conversion of Virclia index values into Platelia values. The study may contribute toward positioning the Virclia assay within the diagnostic algorithm of IPA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalactoseMannansAntigens, FungalAspergillusSensitivity and SpecificityHumansFemaleMaleImmunoassayMiddle AgedInvasive Pulmonary AspergillosisAdultBronchoalveolar Lavage FluidAgedAged, 80 and over

Stichwörter der Autor:innen

AspergillusPlatelia immunoassayVirclia immunoassaygalactomannaninvasive pulmonary aspergillosis

Substanzen

GalactoseMannansgalactomannanAntigens, Fungal

Autor:innen und Institutionen

  • Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Hematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Infectious Diseases Unit, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Pulmonary Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Medical Intensive Care Unit, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.

ORCID-Profile: Eliseo Albert, Nieves Carbonell, David Navarro

Förderung

  • MEC | Instituto de Salud Carlos III (ISCIII)

Zitieren

APA

Albert, E., Alcaraz, M. J., Giménez, E., Clari, M. Á., Torres, I., Colomina, J., Olea, B., Tormo, M., Piñana, J. L., Oltra, R., Signes-Costa, J., Carbonell, N., Solano, C., & Navarro, D. (2024). Comparative performance of the Platelia Aspergillus Antigen and Aspergillus Galactomannan antigen Virclia Monotest immunoassays in serum and lower respiratory tract specimens: a “real-life” experience. Microbiology Spectrum, 12(8). https://doi.org/10.1128/spectrum.03910-23

Vancouver

Albert E, Alcaraz MJ, Giménez E, Clari MÁ, Torres I, Colomina J, et al. Comparative performance of the Platelia Aspergillus Antigen and Aspergillus Galactomannan antigen Virclia Monotest immunoassays in serum and lower respiratory tract specimens: a “real-life” experience. Microbiology Spectrum. 2024;12(8). doi:10.1128/spectrum.03910-23

BibTeX
@article{Albert2024,
  author = {Albert, Eliseo and Alcaraz, María Jesús and Giménez, Estela and Clari, María Ángeles and Torres, Ignacio and Colomina, Javier and Olea, Beatriz and Tormo, Mar and Piñana, José Luis and Oltra, Rosa and Signes-Costa, Jaime and Carbonell, Nieves and Solano, Carlos and Navarro, David},
  title = {Comparative performance of the Platelia Aspergillus Antigen and Aspergillus Galactomannan antigen Virclia Monotest immunoassays in serum and lower respiratory tract specimens: a “real-life” experience},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {8},
  doi = {10.1128/spectrum.03910-23}
}
Kostenlos starten →